A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

ABSTRACT

We examined persisting effects, self-perceived challenges, and potential benefits associated with positive outcomes following ibogaine detoxification using data collected as part of a larger online retrospective study of 73 patients who received treatment for chronic opioid use in Mexico between 2012 and 2015. A mixed-methods design was used comparing treatment responders versus non-responders, as well as content coding of themes from open-ended questions. Most participants reported positive persisting effects of ibogaine detoxification (e.g., enhanced personal sense of gratitude and authenticity, and meaning and appreciation for life). Compared to non-responders, treatment responders endorsed greater persisting changes in their ability to tolerate difficult/painful feelings, capacity for coping with stress, and reduced unhealthy anger. Treatment responders reported greater change in subjective levels of inner peace, joy, feelings of love/openheartedness, and experiences of sacredness in life. Qualitative analyses revealed that treatment responders reported a heightened sense of spiritual awareness and greater connection to their intra-/interpersonal relationships after ibogaine detoxification. Notable challenges of ibogaine detoxification included psychological and health-related difficulties during treatment and challenges with post-treatment integration. Findings highlight the persisting effects associated with positive response to ibogaine detoxification and possible post-treatment needs (i.e., more integration/aftercare resources). Future research using rigorous experimental designs is needed.

KEYWORDS:

• Ibogaine
• heroin
• prescription opioids
• persisting effects

Acknowledgments

The authors acknowledge the participants for sharing their time and insights regarding their experiences. The authors would also like to thank Kirsten J. Lauritsen and Michelle Joyner for their assistance with coding open-ended responses.

Additional information

Funding

During his work on this study, Dr. Davis was initially funded by an National Institute on Alcohol Abuse and Alcoholism training grant (#007747) and subsequently an National Institute on Drug Abuse training grant (#007209). Dr. Barsuglia was employed by Crossroads Treatment Center as Director of Assessment and Research and Dr. Polanco was the medical director and owner of Crossroads Treatment Center during data collection and initial data analysis.